arrow
I

Izumi Kawachi

niigata university
H指数:23
被引数:8,161

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multiancestry genome-wide association and multiomics analyses elucidate spatiocellular features of multiple sclerosis genetics

多血统全基因组关联和多组学分析阐明了多发性硬化遗传学的空间细胞特征

2026-09-070
OAAI
Safety and Effectiveness of Dimethyl Fumarate in Japanese Patients With Multiple Sclerosis: 2-Year Post-Marketing Surveillance Data

富马酸二甲酯在日本多发性硬化患者中的安全性与有效性:上市后2年监测数据

2025-12-010
OAAI
Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 30‑Month Interim Analysis of Post‑marketing Surveillance

日本视神经脊髓炎谱系障碍患者中萨他利珠单抗的安全性及有效性:一项为期30个月的市场后监测中期分析

2025-09-260
OAAI
Effectiveness of satralizumab in a real-world clinical setting in Japan: Interleukin-6 receptor inhibition in neuromyelitis optica spectrum disorder: A six-month interim analysis of a multicenter medical chart review

日本真实世界临床环境中萨特拉利珠单抗的有效性:视神经脊髓炎谱系障碍中的白细胞介素-6受体抑制:一项多中心医疗病历回顾的六个月中期分析

2025-06-010
PRE
Clinical profile of IgG4-related disease in Japan based on the rare disease data registry

基于罕见病数据登记系统的日本IgG4相关疾病的临床特征

2024-11-280
OA
Stage-dependent immunity orchestrates AQP4 antibody-guided NMOSD pathology: a role for netting neutrophils with resident memory T cells in situ
2024-04-241
PRE
Correlation of the symbol digit modalities test with the quality of life and depression in Japanese patients with multiple sclerosis

日本多发性硬化症患者的符号数字模态测试与生活质量和抑郁的相关性

2022-01-013
PRE
HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data

基于日本MS/NMOSD生物库数据的多发性硬化症和视神经脊髓炎谱系障碍的HLA基因型-临床表型相关性

2021-01-1227
OAAI
Clinical and genetic features of Japanese patients with multiple sclerosis and neuromyelitis optica spectrum disorder based on Japan multiple sclerosis biobank
2017-10-010
PREAI